SEVENTH AMENDMENT TO 2005 CREDIT FACILITYCredit Facility Agreement • December 10th, 2007 • Calypte Biomedical Corp • Laboratory analytical instruments • Delaware
THIS SEVENTH AMENDMENT TO 2005 CREDIT FACILITY AGREEMENT (this "Amendment") is made as of December 3, 2007, by and among Calypte Biomedical Corporation, a Delaware corporation ("Issuer"), and Marr Technologies, BV, a limited liability company established in the Netherlands ("Purchaser"). Unless otherwise defined herein, all capitalized terms used herein shall have the meanings given to them in the Credit Facility referred to below.
AMENDMENT NO. 3 TO SECURED 8% CONVERTIBLE PROMISSORY NOTESSecured 8% Convertible Promissory Notes • December 10th, 2007 • Calypte Biomedical Corp • Laboratory analytical instruments • Delaware
THIS AMENDMENT NO. 3 (this "Amendment") to Secured 8% Convertible Promissory Notes, as amended by Amendment No. 2 to Secured 8% Convertible Promissory Notes dated July 3, 2007, and Amendment to Secured 8% Convertible Promissory Notes dated March 21, 2007 (each, a “Note,” and collectively, the "Notes"), is made as of December 3, 2007, by and between Calypte Biomedical Corporation, a Delaware corporation (the "Company"), and Marr Technologies BV, a limited liability company established in the Netherlands (the “Investor”). If there is any inconsistency between the terms of this Amendment and any other agreement referenced herein, the terms of this Amendment will govern.
